# MESALAMINE
> **ANDA207873** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-05-09
## Drug
- **FDA Application Number:** ANDA207873
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MESALAMINE
- **Generic name:** MESALAMINE
- **Active ingredients:** MESALAMINE
- **Dosage form:** CAPSULE, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2019-05-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207873)
---
*MORVS · CC0 1.0*